Sen. Bill Cassidy (R-LA) is putting march-in authority back in his crosshairs in the wake of the Supreme Court's decision to overturn the Chevron deference, which required courts to defer to agency interpretations of ambiguous statutory provisions. In a letter sent to HHS Secretary Xavier Becerra on Sunday (June 30), the ranking Republican on the Senate health committee requested the secretary clarify the legal basis for the National Institutes of Health’s (NIH) proposed framework to use drug pricing as...